Price loading...

U.S. Drug Supply, Investigational Drugs and E-Prescriptions

Law

Price data last checked 103 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

No Price Data Available

Price history will appear here once data is collected from Amazon.

Price Distribution

No price data available for histogram

Description

Chapter 1 reports on the U.S. drug supply and the complex way it is interwoven with multiple stakeholders involved in each step of the process. When investigational drugs show promise for treating serious or life-threatening diseases, patients are often interested in obtaining access to them. Congress included a provision in the FDA Reauthorization Act of 2017 for GAO to review actions taken to facilitate access to these drugs. Chapter 2 describes (1) actions FDA and drug manufacturers have taken to broaden eligibility criteria for clinical trials, (2) actions FDA has taken to facilitate access to investigational drugs outside of clinical trials, and (3) information drug manufacturers have communicated to patients and physicians about access to investigational drugs outside of clinical trials. Chapter 3 reports on requiring e-prescriptions for coverage under part D of the Medicare program for prescription drugs that are controlled substances.

Product Specifications

Format: hardcover
ASIN: 1536174424
Category: Books > Subjects > Business, Finance & Law > Law
Domain: Amazon UK
Release Date: 03 March 2020
Listed Since: 14 January 2020

Barcode

No barcode data available

U.S. Drug Supply, Investigational Drugs and E-Prescriptions

Price History & Forecast

No Price Data Available

Price Distribution

Description

Product Specifications

Barcode

Similar Products You Might Like

Progress in Medical Research: Government Programs and Key Issues (Medical Procedures, Testing and Technology)

Medicare: Value-Based Care, Pharmacy Benefit Managers, Trust Fund Reports and Fee-For-Service (Health Care in Transition)

Propelling Innovation in New Drugs: Recommendations & Considerations (Pharmacology-Research, Safety Testing and Regulation)

Prescription Drugs: Development, Pricing and Abuse (Health Care in Transition)

Research and Development in the Pharmaceutical Industry

PRESCRIPTION DRUGS (Substance Abuse Assassment Interventions and Treatment)

Pet Medications industry: Overview, Competition & Distribution Issues

Pharmaceutical Supply Chain: Drug Quality and Security Act

Prescription Drugs & the DEA: Interactions & Issues with Controlled Substances Registrants

Drug Control in the United States: 2014 Strategy and an Appraisal of Past Policy (Drug Transit and Distribution, Interception and Control)

Prescription Drug Pricing: Cost & Control Concerns (Health Care Issues, Costs and Access)

Pharmaceutical Industry: Innovation & Developments (Business Issues, Competition and Entrepreneurship)

Medicare s Prescription Drug Program: Competition Issues & Cost Trends

Electronic Health Records: Overview, Challenges and Legislation

Federal Drug Enforcement: History, Policies, Trends (Drug Transit and Distribution, Interception and Control)

Defense Health Care: Treatment, Performance and TRICARE

Drug Approval and Evaluation, Delivery and Control: Approval & Evaluation, Delivery & Control

Pharmacovigilance: A Practical Approach

The New Medicines: How Drugs are Created, Approved, Marketed, and Sold

FDA Regulatory Affairs: A Guide for Prescription Drugs, Medical Devices, and Biologics

Opioid Use and Misuse in the Medicare System - Nova Science

Health Care in the United States: Developments and Considerations -- Volume 5

Pharmaceutical Public Policy

Dealing with Drugs: Control, Prevention & Treatment (Public Health in the 21st Century)